Option Care Health, Inc.

$22.23+6.57%(+$1.37)
TickerSpark Score
63/100
Mixed
80
Valuation
65
Profitability
60
Growth
80
Health
30
Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a OPCH research report →

52-Week Range22% of range
Low $18.01
Current $22.23
High $36.80

Companywww.optioncarehealth.com

Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.

CEO
Luke Whitworth
IPO
1996
Employees
8,000
HQ
Bannockburn, IL, US

Price Chart

-32.78% · this period
$36.59$28.05$19.52May 20Nov 18May 20

Valuation

Market Cap
$3.49B
P/E
16.89
P/S
0.62
P/B
2.58
EV/EBITDA
8.16
Div Yield
0.00%

Profitability

Gross Margin
18.00%
Op Margin
5.93%
Net Margin
3.64%
ROE
15.28%
ROIC
9.32%

Growth & Income

Revenue
$5.65B · 13.03%
Net Income
$207.59M · -2.00%
EPS
$1.28 · 4.07%
Op Income
$337.91M
FCF YoY
-10.19%

Performance & Tape

52W High
$36.80
52W Low
$18.01
50D MA
$26.12
200D MA
$29.33
Beta
0.68
Avg Volume
2.89M

Get TickerSpark's AI analysis on OPCH

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Recent Insider Transactions

DateInsiderTypeShares
May 7, 26SULLIVAN TIMOTHY Pbuy24,154
May 4, 26KRAEMER HARRY M JANSEN JRbuy36,610
May 4, 26Sethna Meenalbuy16,225
May 4, 26RADEMACHER JOHN CHARLESbuy12,500
Apr 22, 26Adewunmi Femiother1,396
Feb 27, 26Pate R Cartersell30,287
Feb 27, 26Bavaro Michaelsell6,000
Feb 24, 26Whitworth Lukeother4,605
Feb 24, 26Grashoff Christopher L.other1,980
Feb 24, 26Smyser Collinother2,210

Our OPCH Coverage

We haven't published any research on OPCH yet

For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.

Generate OPCH Report →

Similar Companies